303 results on '"Micheletto, Claudio"'
Search Results
2. Development and validation of a prediction score to assess the risk of incurring in COPD-related exacerbations: a population-based study in primary care
3. Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort
4. Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy
5. Second running title: Prediction of COPD-related exacerbations
6. Exacerbation Burden in COPD and Occurrence of Mortality in a Cohort of Italian Patients: Results of the Gulp Study
7. Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life Study
8. Dupilumab Efficacy on Asthma Functional, Inflammatory, and Patient-Reported Outcomes across Different Disease Phenotypes and Severity: A Real-Life Perspective
9. Lung cancer and interstitial lung diseases: the lack of prognostic impact of lung cancer in IPF
10. Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life Study.
11. Long-Term Patient-Centred Follow-up in a Prospective Cohort of Patients with COVID-19
12. CT radiomic models to distinguish COVID-19 pneumonia from other interstitial pneumonias
13. Safety of dupilumab in T2 airways conditions: focus on eosinophilia across trials and real-life evidence
14. Exercise prehabilitation in lung cancer: Getting stronger to recover faster
15. Review for "Safety and efficacy of bronchial thermoplasty in refractory asthma with severe obstructive respiratory dysfunction"
16. The Burden of Short-Acting β2-Agonist Use in Asthma: Is There an Italian Case? An Update from SABINA Program
17. Prevalence of SARS-CoV-2, Verona, Italy, April-May 2020
18. Assessment of COVID-19 progression on day 5 from symptoms onset
19. ROX index on 3rd day as a best predictor of treatment failure in severe COVID-19 patients
20. Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort
21. Correction to: Lung cancer and interstitial lung diseases: the lack of prognostic impact of lung cancer in IPF
22. Gestione del rischio clinico in terapia intensiva respiratoria: risultati di un approccio prospettico.
23. Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy
24. Sex differences in excessive oral corticosteroid exposure in poor adherent adult asthmatics overusing short-acting β-2 agonists.
25. Antimicrobial Stewardship in COVID-19 Patients: Those Who Sow Will Reap Even through Hard Times
26. Variation in costs due to virtual switching from free- to fixed-triple LABA/LAMA/ICS combinations among COPD patients: an analysis using a primary care database
27. Omalizumab management beyond clinical trials: The added value of a network model
28. Clinical Outcomes
29. Dupilumab-induced hypereosinophilia: review of the literature and algorithm proposal for clinical management
30. Integrating supportive care into the multidisciplinary management of lung cancer: we can’t wait any longer
31. Il controllo dell’asma bronchiale: come definirlo e come ottenerlo.
32. Determinants of persistence of symptoms and impact on physical and mental wellbeing in Long COVID: A prospective cohort study
33. Effects of anti‐IL5 biological treatments on blood IgE levels in severe asthmatic patients: A real‐life multicentre study (BIONIGE)
34. Variation in costs due to virtual switching from free- to fixed-triple LABA/LAMA/ICS combinations among COPD patients: an analysis using a primary care database
35. Multidisciplinary management in type 2 inflammatory disease
36. Future Perspectives of Revaluating Mild COPD
37. ARIA-ITALY multidisciplinary consensus on nasal polyposis and biological treatments
38. Correction to: Lung cancer and interstitial lung diseases: the lack of prognostic impact of lung cancer in IPF
39. Cost-effectiveness of consolidation durvalumab after chemo-radiotherapy in stage III non-small-cell lung cancer: A cost-effective change
40. Lung cancer and interstitial lung diseases: the lack of prognostic impact of lung cancer in IPF
41. Oral corticosteroids-related comorbidities in severe asthma
42. Triple combination therapy in severe asthma: overview from the Italian Registry Severe Asthma (IRSA)
43. Late Breaking Abstract - Relationship between clinical features and mortality in a cohort of COPD patients
44. Biomarkers for the management of severe asthma: a survey
45. Evaluation of Asthma control and oral corticosteroids in Severe Asthma
46. Organization, Clinical and Management Indicators on the First Year of Activity of an Outpatient Clinic Dedicated to the Diagnosis and Treatment of Severe Asthma in Italy
47. Multidisciplinary management of type 2 inflammatory diseases.
48. Mepolizumab 100 mg in severe asthmatic patients with EGPA in remission phase
49. Reply to “Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?”
50. Sex differences in excessive oral corticosteroid exposure in poor adherent adult asthmatics overusing short-acting β-2 agonists
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.